As presented in Figure 5B–D, the expression of the receptor activator of nuclear factor kappaB (RANK), the nuclear factor of activated T cell cytoplasmic 1 (NFATc1), and TRAP was significantly increased during CKD development. This evidence concerns the gene ACP5 and chronic kidney disease.